Weekly platinum chemotherapy for recurrent ovarian cancer

被引:2
作者
Clamp, A [1 ]
Jayson, GC [1 ]
机构
[1] Christie Hosp NHS Trust, CRC Dept Med Oncol, Manchester M20 4BX, Lancs, England
关键词
D O I
10.1038/sj.bjc.6600062
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
引用
收藏
页码:2 / 4
页数:3
相关论文
共 31 条
[1]
ANDERSSON H, 2000, P AN M AM SOC CLIN, V18, pA1505
[2]
BELINSON J, 2000, P AN M AM SOC CLIN, V18, pA1553
[3]
RESPONSE OF PATIENTS IN PHASE-II STUDIES OF CHEMOTHERAPY IN OVARIAN-CANCER - IMPLICATIONS FOR PATIENT TREATMENT AND THE DESIGN OF PHASE-II TRIALS [J].
BLACKLEDGE, G ;
LAWTON, F ;
REDMAN, C ;
KELLY, K .
BRITISH JOURNAL OF CANCER, 1989, 59 (04) :650-653
[4]
BOLANOS M, 2001, P AN M AM SOC CLIN, V19, pA870
[5]
Weekly cisplatin given for 2 months versus cisplatin plus cyclophosphamide given for 5 months after cytoreductive surgery for advanced ovarian cancer [J].
Bolis, G ;
Favalli, G ;
Danese, S ;
Zanaboni, F ;
Mangili, G ;
Scarabelli, C ;
Tateo, S ;
Valsecchi, MG ;
Scarfone, G ;
Richiardi, G ;
Frigerio, I ;
Melpignano, M ;
Villa, A ;
Parazzini, F .
JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (05) :1938-1944
[6]
RESPONSE TO 2ND-LINE WEEKLY CISPLATIN CHEMOTHERAPY IN OVARIAN-CANCER PREVIOUSLY TREATED WITH A CISPLATIN-BASED OR CARBOPLATIN-BASED REGIMEN [J].
BOLIS, G ;
SCARFONE, G ;
LUCHINI, L ;
FERRARIS, C ;
ZANABONI, F ;
PRESTI, M ;
GIARDINA, G ;
VILLA, A ;
PARAZZINI, F .
EUROPEAN JOURNAL OF CANCER, 1994, 30A (12) :1764-1768
[7]
Docetaxel administered on a weekly basis for metastatic breast cancer [J].
Burstein, HJ ;
Manola, J ;
Younger, J ;
Parker, LM ;
Bunnell, CA ;
Scheib, R ;
Matulonis, UA ;
Garber, JE ;
Clarke, KD ;
Shulman, LN ;
Winer, EP .
JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (06) :1212-1219
[8]
Mature results of a prospective randomized trial comparing a three-weekly with an accelerated weekly schedule of cisplatin in advanced ovarian carcinoma [J].
Cocconi, G ;
Bella, M ;
Lottici, R ;
Leonardi, F ;
Ceci, G ;
Passalacqua, R ;
Di Blasio, B ;
Bordi, C ;
Biscottini, B ;
Melpignano, M ;
De Biasi, D ;
Finardi, C ;
Bacchi, M .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1999, 22 (06) :559-567
[9]
COLOMBO N, 1993, P AN M AM SOC CLIN, V12, pA806
[10]
PHASE-II STUDY OF PROLONGED ORAL ETOPOSIDE IN PATIENTS WITH OVARIAN-CANCER REFRACTORY TO OR RELAPSING WITHIN 12 MONTHS AFTER PLATINUM-CONTAINING CHEMOTHERAPY [J].
DEWIT, R ;
VANDERBURG, MEL ;
VANDERGAAST, A ;
LOGMANS, A ;
STOTER, G ;
VERWEIJ, J .
ANNALS OF ONCOLOGY, 1994, 5 (07) :656-657